Diagnostics & Research Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1293 |  SHC Sotera Health Company - Common Stock | 17.59 USD | -1.73% | -3.77% | -4.45% | +4.33% | 5.02 B USD | ||
| 1378 |  BLLN BillionToOne, Inc. - Class A common stock | 94.76 USD | -1.03% | -9.82% | -2.85% | -5.24% | 4.47 B USD | ||
| 1596 |  CDNA CareDx, Inc. - Common Stock | 62.32 USD | -1.14% | -6.12% | +24.94% | +317.97% | 3.22 B USD | ||
| 1766 |  NEOG Neogen Corporation - Common Stock | 11.88 USD | +1.71% | -6.16% | -1.74% | +80.00% | 2.59 B USD | ||
| 1942 |  NEO NeoGenomics, Inc. - Common Stock | 15.52 USD | -2.82% | -14.91% | -10.19% | +69.43% | 1.99 B USD | ||
| 2051 |  PSNL Personalis, Inc. - Common Stock | 16.01 USD | +0.06% | -1.42% | -3.55% | +82.35% | 1.71 B USD | ||
| 2375 |  OPK Opko Health, Inc. - Common Stock | 1.36 USD | -2.16% | -12.82% | -13.92% | -12.26% | 1.02 B USD | ||
| 2380 |  CSTL Castle Biosciences, Inc. - Common stock | 32.94 USD | -0.18% | -9.23% | +1.57% | +33.85% | 1.01 B USD | ||
| 2792 |  FLGT Fulgent Genetics, Inc. - Common Stock | 19.92 USD | -3.16% | -8.16% | -0.85% | -15.70% | 548.10 M USD | ||
| 2827 |  ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.52 USD | +3.53% | -28.02% | -40.94% | +83.33% | 518.14 M USD | ||
| 3015 |  MYGN Myriad Genetics, Inc. - Common Stock | 4.14 USD | -3.27% | -2.82% | +33.12% | -49.94% | 395.99 M USD | ||
| 3063 |  PRE Prenetics Global Limited - Class A Ordinary Share | 22.05 USD | -1.87% | -2.09% | -13.53% | +49.49% | 372.07 M USD | ||
| 3331 |  BDSX Biodesix, Inc. - Common Stock | 25.53 USD | -3.37% | -9.15% | -4.63% | +104.08% | 269.37 M USD | ||
| 3376 |  LAB Standard BioTools Inc. - Common Stock | 0.65 USD | -4.41% | -10.96% | -5.80% | -50.38% | 255.18 M USD | ||
| 3566 |  XGN Exagen Inc. - Common Stock | 8.04 USD | -3.13% | 0.00% | +9.99% | -26.84% | 194.77 M USD | ||
| 3640 |  BNR Burning Rock Biotech Limited - American Depositary Shares | 14.50 USD | -4.48% | -14.45% | +30.75% | -51.54% | 156.90 M USD | ||
| 3647 |  STIM Neuronetics, Inc. - Common Stock | 2.13 USD | -1.84% | -5.75% | -26.80% | -29.24% | 162.30 M USD | ||
| 3846 |  IMDX Insight Molecular Diagnostics Inc. - Common Stock | 3.18 USD | -8.09% | -10.42% | -25.35% | -13.35% | 104.06 M USD | ||
| 4098 |  DRIO DarioHealth Corp. - Common Stock | 5.79 USD | -4.77% | -9.81% | -17.64% | -48.16% | 56.74 M USD | ||
| 4257 |  PRPO Precipio, Inc. - Common Stock | 22.90 USD | -2.64% | -1.72% | -15.50% | +9.10% | 41.00 M USD |
News Diagnostics & Research Stocks
bioAffinity Technologies Commences ~$4M Offering Of Common Stock At $6.122 Per Share
Why Is Neogen Stock Gaining Thursday?
Neogen Corporation Stock: Promising Recurring Demand With Food Safety (NASDAQ:NEOG)
Bruker Gains 66.3% in a Year: What's Driving the Rally?
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research
Here's Why You Should Retain WAT Stock in Your Portfolio for Now
SOPHiA GENETICS, Myriad Genetics Collaborate To Advance New Prostate Cancer-specific Genomic Instability Score Technology
Gainers Diagnostics & Research Stocks
 BIAFW bioAffinity Technologies, Inc. - Warrant | 0.5699 | +60.49% |
 BIAF bioAffinity Technologies, Inc. - Common Stock | 8.01 | +30.03% |
 STRR Star Equity Holdings, Inc. - Common Stock | 10.35 | +6.59% |
 VNRX VolitionRX Limited Common Stock | 0.23 | +4.55% |
ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.52 | +3.53% |
NEOG Neogen Corporation - Common Stock | 11.88 | +1.71% |
 XWEL XWELL, Inc. - Common Stock | 0.91 | +1.11% |
 IDXX IDEXX Laboratories, Inc. - Common Stock | 510.12 | +0.68% |
